Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Benefit-Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.

Stein A, Franklin JL, Chia VM, Arrindell D, Kormany W, Wright J, Parson M, Amouzadeh HR, Choudhry J, Joseph G.

Drug Saf. 2019 May;42(5):587-601. doi: 10.1007/s40264-018-0760-1. Review.

2.

Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with ALL.

Kim C, Molony JT, Chia VM, Kota VK, Katz AJ, Li S.

Leuk Lymphoma. 2019 Jun;60(6):1462-1468. doi: 10.1080/10428194.2018.1538505. Epub 2018 Dec 13.

PMID:
30541363
3.

Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.

Katz AJ, Chia VM, Schoonen WM, Kelsh MA.

Cancer Causes Control. 2015 Nov;26(11):1627-42. doi: 10.1007/s10552-015-0657-6. Epub 2015 Sep 16.

PMID:
26376890
4.

History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis.

Chao C, Page JH, Yang SJ, Rodriguez R, Huynh J, Chia VM.

Ann Oncol. 2014 Sep;25(9):1821-9. doi: 10.1093/annonc/mdu203. Epub 2014 Jun 10.

PMID:
24915871
5.

History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis.

Chao C, Rodriguez R, Page JH, Yang SJ, Huynh J, Chia VM.

Leuk Lymphoma. 2015 Jan;56(1):72-9. doi: 10.3109/10428194.2014.905773. Epub 2014 May 2.

PMID:
24684228
6.

Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma.

Langeberg WJ, Siozon CC, Page JH, Morrow PK, Chia VM.

Support Care Cancer. 2014 Aug;22(8):2167-75. doi: 10.1007/s00520-014-2184-5. Epub 2014 Mar 21.

PMID:
24652049
7.

Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy.

Choi MR, Solid CA, Chia VM, Blaes AH, Page JH, Barron R, Arneson TJ.

Support Care Cancer. 2014 Jun;22(6):1619-28. doi: 10.1007/s00520-014-2121-7. Epub 2014 Feb 4.

PMID:
24492928
8.

Innate immunity gene polymorphisms and the risk of colorectal neoplasia.

Chang CM, Chia VM, Gunter MJ, Zanetti KA, Ryan BM, Goodman JE, Harris CC, Weissfeld J, Huang WY, Chanock S, Yeager M, Hayes RB, Berndt SI; Genetics and Epidemiology of Colorectal Cancer Consortium.

Carcinogenesis. 2013 Nov;34(11):2512-20. doi: 10.1093/carcin/bgt228. Epub 2013 Jun 26.

9.

Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: a nationwide population-based cohort study in Denmark.

Svendsen ML, Gammelager H, Sværke C, Yong M, Chia VM, Christiansen CF, Fryzek JP.

Clin Epidemiol. 2013;5:97-103. doi: 10.2147/CLEP.S42325. Epub 2013 Mar 26.

10.

An international assessment of ovarian cancer incidence and mortality.

Lowe KA, Chia VM, Taylor A, O'Malley C, Kelsh M, Mohamed M, Mowat FS, Goff B.

Gynecol Oncol. 2013 Jul;130(1):107-14. doi: 10.1016/j.ygyno.2013.03.026. Epub 2013 Apr 2.

PMID:
23558050
11.

Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy.

Chia VM, Page JH, Rodriguez R, Yang SJ, Huynh J, Chao C.

Breast Cancer Res Treat. 2013 Apr;138(2):621-31. doi: 10.1007/s10549-013-2454-9. Epub 2013 Mar 7.

PMID:
23468242
12.

Prevalence and incidence of comorbidities in elderly women with ovarian cancer.

Chia VM, O'Malley CD, Danese MD, Lindquist KJ, Gleeson ML, Kelsh MA, Griffiths RI.

Gynecol Oncol. 2013 May;129(2):346-52. doi: 10.1016/j.ygyno.2013.02.014. Epub 2013 Feb 17.

PMID:
23422502
13.

Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.

Dallal CM, Brinton LA, Bauer DC, Buist DS, Cauley JA, Hue TF, Lacroix A, Tice JA, Chia VM, Falk R, Pfeiffer R, Pollak M, Veenstra TD, Xu X, Lacey JV Jr; B~FIT Research Group.

Endocr Relat Cancer. 2013 Feb 18;20(1):151-60. doi: 10.1530/ERC-12-0229. Print 2013 Feb.

14.

Estimated number of prevalent cases of metastatic bone disease in the US adult population.

Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ.

Clin Epidemiol. 2012;4:87-93. doi: 10.2147/CLEP.S28339. Epub 2012 Apr 10.

15.

Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.

Lacey JV Jr, Chia VM, Rush BB, Carreon DJ, Richesson DA, Ioffe OB, Ronnett BM, Chatterjee N, Langholz B, Sherman ME, Glass AG.

Int J Cancer. 2012 Oct 15;131(8):1921-9. doi: 10.1002/ijc.27457. Epub 2012 Mar 14.

16.

Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.

Griffiths RI, Barron RL, Gleeson ML, Danese MD, O'Hagan A, Chia VM, Legg JC, Lyman GH.

Pharmacoeconomics. 2012 Feb 1;30(2):103-18. doi: 10.2165/11589440-000000000-00000.

PMID:
21967155
17.

Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women.

Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD.

Br J Cancer. 2011 Mar 1;104(5):763-8. doi: 10.1038/sj.bjc.6606041. Epub 2011 Feb 8.

18.

Genetic contributions to the association between adult height and testicular germ cell tumors.

Cook MB, Chia VM, Berndt SI, Graubard BI, Chanock SJ, Rubertone MV, Erickson RL, Hayes RB, McGlynn KA.

Int J Epidemiol. 2011 Jun;40(3):731-9. doi: 10.1093/ije/dyq260. Epub 2011 Jan 13.

19.

Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps.

Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT.

Growth Horm IGF Res. 2010 Aug;20(4):305-9. doi: 10.1016/j.ghir.2010.04.001. Epub 2010 May 26.

20.

International trends in the incidence of testicular cancer, 1973-2002.

Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1151-9. doi: 10.1158/1055-9965.EPI-10-0031.

21.

Effect modification of endocrine disruptors and testicular germ cell tumour risk by hormone-metabolizing genes.

Chia VM, Li Y, Quraishi SM, Graubard BI, Figueroa JD, Weber JP, Chanock SJ, Rubertone MV, Erickson RL, McGlynn KA.

Int J Androl. 2010 Aug 1;33(4):588-96. doi: 10.1111/j.1365-2605.2009.00975.x. Epub 2009 Jul 20.

22.

Endometrial hyperplasia and the risk of progression to carcinoma.

Lacey JV Jr, Chia VM.

Maturitas. 2009 May 20;63(1):39-44. doi: 10.1016/j.maturitas.2009.02.005. Epub 2009 Mar 13. Review.

PMID:
19285814
23.

Risk of cancer in first- and second-degree relatives of testicular germ cell tumor cases and controls.

Chia VM, Li Y, Goldin LR, Graubard BI, Greene MH, Korde L, Rubertone MV, Erickson RL, McGlynn KA.

Int J Cancer. 2009 Feb 15;124(4):952-7. doi: 10.1002/ijc.23971.

24.

Hormone therapy in relation to survival from large bowel cancer.

Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Trentham Dietz A.

Cancer Causes Control. 2009 May;20(4):409-16. doi: 10.1007/s10552-008-9255-1. Epub 2008 Nov 9.

25.

Insulin-like growth factor 1, insulin-like growth factor-binding protein 3, and testicular germ-cell tumor risk.

Chia VM, Quraishi SM, Graubard BI, Rubertone MV, Erickson RL, Stanczyk FZ, McGlynn KA.

Am J Epidemiol. 2008 Jun 15;167(12):1438-45. doi: 10.1093/aje/kwn080. Epub 2008 Apr 11.

PMID:
18408226
26.

Risk of testicular germ cell tumors and polymorphisms in the insulin-like growth factor genes.

Chia VM, Sakoda LC, Graubard BI, Rubertone MV, Chanock SJ, Erickson RL, McGlynn KA.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):721-6. doi: 10.1158/1055-9965.EPI-07-0768.

27.

Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements.

Chia VM, Newcomb PA, White E, Zheng Y, Potter JD, Lampe JW.

Horm Res. 2008;69(5):295-300. doi: 10.1159/000114861. Epub 2008 Feb 6.

PMID:
18259109
28.

Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk.

Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2697-703.

29.

Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women.

Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter JD.

Cancer Res. 2007 Aug 1;67(15):7534-9.

30.

Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis.

Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM.

Int J Gynecol Cancer. 2007 Mar-Apr;17(2):441-6.

PMID:
17362320
31.

Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.

Chia VM, Newcomb PA, Bigler J, Morimoto LM, Thibodeau SN, Potter JD.

Cancer Res. 2006 Jul 1;66(13):6877-83.

Supplemental Content

Support Center